RTW Biotech Opportunities (LON:RTW – Get Free Report) reached a new 52-week high on Saturday . The company traded as high as GBX 1.61 ($0.02) and last traded at GBX 1.61 ($0.02), with a volume of 3115999 shares trading hands. The stock had previously closed at GBX 1.59 ($0.02).
RTW Biotech Opportunities Stock Performance
The company has a market capitalization of £5.27 million, a P/E ratio of -6.19 and a beta of 0.60. The firm has a 50 day moving average price of GBX 1.46 and a two-hundred day moving average price of GBX 1.29.
About RTW Biotech Opportunities
RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives.
Further Reading
- Five stocks we like better than RTW Biotech Opportunities
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Microsoft 365 Premium Marks the Next Phase of AI Monetization
- The Role Economic Reports Play in a Successful Investment Strategy
- Could Target’s Week of Discounts Come Full Circle for Investors?
- Trading Halts Explained
- 3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
